These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1945284)

  • 1. Further observations on the prevention of experimental proliferative vitreo-retinopathy by 5-fluorouracil.
    Ophir A
    Ophthalmic Res; 1991; 23(3):128-32. PubMed ID: 1945284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil.
    Rubsamen PE; Davis PA; Hernandez E; O'Grady GE; Cousins SW
    Arch Ophthalmol; 1994 Mar; 112(3):407-13. PubMed ID: 8129669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.
    Steinhorst UH; Chen EP; Hatchell DL; Samsa GP; Saloupis PT; Westendorf J; Machemer R
    Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1753-60. PubMed ID: 8473115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of 5-fluorouridine and 5-fluorouracil in an experimental model for the treatment of vitreoretinal scarring.
    Ward T; Hartzer M; Blumenkranz M; Lin LR
    Curr Eye Res; 1993 May; 12(5):397-401. PubMed ID: 8344064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 3,3'-iminodipropionitrile on experimental intravitreal proliferation in albino rabbits.
    Akiyama K
    Jpn J Ophthalmol; 1990; 34(4):401-8. PubMed ID: 2082060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorouracil for the treatment of massive periretinal proliferation.
    Blumenkranz MS; Ophir A; Claflin AJ; Hajek A
    Am J Ophthalmol; 1982 Oct; 94(4):458-67. PubMed ID: 6182799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of experimental massive peri-retinal proliferation by 5-fluoro-uracil.
    Ophir A
    Metab Pediatr Syst Ophthalmol; 1983; 7(2):109-13. PubMed ID: 6656618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intraocular proliferations with intravitreal steroids.
    Machemer R; Sugita G; Tano Y
    Trans Am Ophthalmol Soc; 1979; 77():171-80. PubMed ID: 545825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.
    Stern WH; Lewis GP; Erickson PA; Guerin CJ; Anderson DH; Fisher SK; O'Donnell JJ
    Am J Ophthalmol; 1983 Jul; 96(1):33-42. PubMed ID: 6869478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cytotoxic drugs on proliferative vitreoretinopathy in the rabbit cell injection model.
    Sunalp M; Wiedemann P; Sorgente N; Ryan SJ
    Curr Eye Res; 1984 Apr; 3(4):619-23. PubMed ID: 6425019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fellow eyes of giant retinal breaks.
    Freeman HM
    Trans Am Ophthalmol Soc; 1978; 76():343-82. PubMed ID: 754378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy.
    Joondeph BC; Peyman GA; Khoobehi B; Yue BY
    Ophthalmic Surg; 1988 Apr; 19(4):252-6. PubMed ID: 3362494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of drug treatments for proliferative vitreoretinopathy using vitreous microtensiometry.
    Moorhead LC; Sepahban S; Armeniades CD
    Ann Ophthalmol; 1991 Sep; 23(9):349-55. PubMed ID: 1741609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fellow eyes of giant retinal breaks.
    Freeman HM
    Mod Probl Ophthalmol; 1979; 20():267-74. PubMed ID: 548756
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravitreal 5-fluorouracil in the prevention of post-traumatic vitreous proliferation.
    Avni I; Belkin M; Hercberg A; Blumenthal M
    Ophthalmologica; 1984; 188(1):5-8. PubMed ID: 6700951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
    Berger AS; Cheng CK; Pearson PA; Ashton P; Crooks PA; Cynkowski T; Cynkowska G; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irradiation pretreatment before fibroblast implantation in experimental PVR.
    Velikay M; Stolba U; Wedrich A; Datlinger P; Binder S; Handl-Zeller L
    Int Ophthalmol; 1993 Aug; 17(4):191-3. PubMed ID: 8112965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite.
    Blumenkranz M; Hernandez E; Ophir A; Norton EW
    Ophthalmology; 1984 Feb; 91(2):122-30. PubMed ID: 6709326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy.
    Kirmani M; Santana M; Sorgente N; Wiedemann P; Ryan SJ
    Retina; 1983; 3(4):269-72. PubMed ID: 6201971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of experimental proliferative vitreoretinopathy in the rabbit eye by intravitreal injections of fibroblast growth factor.
    Baudouin C; Fredj-Reygrobellet D; Ettaiche M; Barritault D; Gastaud P; Lapalus P
    Lens Eye Toxic Res; 1992; 9(3-4):505-11. PubMed ID: 1284520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.